Corona Update: Bharat Biotech’s corona vaccine Covaxin may get the approval of the World Health Organization (WHO) this week. Although vaccines are already being vaccinated in India, but after getting the approval of WHO, it will get acceptance all over the world and people going abroad will not hesitate to get it vaccinated. So far this vaccine is no longer included in the WHO’s list of emergency use, due to which many countries have not approved the travel of people who have got the vaccine. Many countries in Europe have also not recognized the vaccine vaccine on the basis that it is not included in the vaccines recognized by WHO. In such a situation, despite getting both its vaccines, people had to undergo compulsory quarantine abroad. In such a situation, if this vaccine gets the approval of WHO, then all NRIs and students and professionals going abroad will be able to get this vaccine without any hesitation.
This has not been confirmed yet, but according to media sources, Bharat Biotech’s COVID19 vaccine is expected to get World Health Organization approval by this week. Along with this, it will also be easier for people vaccinated with the vaccine to travel to any country. Covaccine is a completely indigenous vaccine, and its emergency use has been approved by the Government of India. Covaxin has been jointly developed by ICMR and Bharat Biotech.
Currently, Bharat Biotech’s Corona Vaccine Covaccine, Serum Institute of India’s Kovishield and Russian Vaccine Sputnik V are being installed in the country. Along with this, the Drugs Controller General of India has approved Reliance Life Sciences for the first phase clinical trial of its indigenously developed Kovid-19 vaccine with certain conditions. According to the data of the Union Ministry of Health and Family Welfare, till September 12, at least more than 75 crore corona vaccine doses have been given.